Roger Sidhu, M.D. has served as Brooklyn’s Chief Medical Officer since September 2021. Prior to that time, he served as Executive Vice President, Head of Research and Development and Chief Medical Officer of Roivant Sciences Ltd., a healthcare company focused on applying technology to drug development, from July 2020 to July 2021. From January 2018 to January 2020, Dr. Sidhu was Vice President, Clinical Development of Kite Pharma, Inc., a pharmaceutical company focused on cell therapy and subsidiary of Gilead Sciences, Inc. Dr. Sidhu was Chief Medical Officer of Cell Design Labs, Inc., a biotechnology company developing cell-based therapies, from February 2017 to January 2018. From 2009 to January 2017, Dr. Sidhu served Amgen, Inc., a biopharmaceutical company, in various roles of increasing responsibility, including Global Product General Manager, Translational Sciences, from May 2016 to January 2017. Dr. Sidhu holds an M.D. from Queen’s University and a BSc in Biochemistry from the University of Alberta.